Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

March 01, 2024 0:44 (London Time)

Vaxart

Youtube Subscribe

...

Sector: Biotechnology
Ticker: VXRT
Sentiment: 0.2944
MarketCap: 199,431,693.0
High: 1.31 Low: 1.21

Open: 1.29 Close: 1.22 Change: -0.07

The best way to get informed about Vaxart Company Inc Stock without reading hundreds of pages.

The game is changing. There is a new strategy to evaluate Vaxart fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Vaxart are: Vaxart, mil, ticker, share, Inc, vaxrt, worth, and the …

Concept Map

...

Semantic Network

...

Stock Summary

Vaxart, Inc. engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase.

Today's Summary

Vaxart, Inc. (vaxrt) worth $187 mil (down $-12 mil), still more valuable than /*err: invalid ticker symbol. Only non-blank, uppercase tickers supported.*/ $1.30. vaxart (vxrt) stock price, news, quotes-moomoo.com. Vaxart is a bad long-term investment option. Vaxart (VXRT) reported earnings of -$0.11 per share, beating the Zacks Consensus Estimate of $-0.18 per share. This is Amgens second round of layoffs this year, with 300 members of staff.

Today's News

Vaxart, Inc. (vaxrt) worth $187 mil (down $-12 mil), still more valuable than /*err: invalid ticker symbol. Only non-blank, uppercase tickers supported.*/ $1.30. vaxart (vxrt) stock price, news, quotes-moomoo.com. Vaxart is a bad long-term investment option. Vaxart (VXRT) reported earnings of -$0.11 per share, beating the Zacks Consensus Estimate of $-0.18 per share. This is Amgens second round of layoffs this year, with 300 members of staff.

Stock Profile

"Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase II clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trial for the treatment of H1 influenza infection; respiratory syncytial virus vaccine, an oral vaccine platform, which is in preclinical stage; coronavirus vaccine, which is in Phase II clinical trial for the treatment of SARS-CoV-2 infection; human papillomavirus therapeutic vaccine that targets HPV 16 and HPV 18 for cervical cancers and precancerous cervical dysplasia. The company has license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California."

Keywords

This document will help you to evaluate Vaxart without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Vaxart are: Vaxart, mil, ticker, share, Inc, vaxrt, worth, and the most common words in the summary are: stock, vaxart, forecast, price, inc, close, open, . One of the sentences in the summary was: (vaxrt) worth $187 mil (down $-12 mil), still more valuable than /*err: invalid ticker symbol. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #stock #vaxart #forecast #price #inc #close #open.

Read more →

Related Results

...
March 01, 2024 0:44 (London Time)

Vaxart

Vaxart, Inc. (vaxrt) worth $187 mil (down $-12 mil), still more valuable than /*err: invalid ticker symbol. Only non-blank, uppercase tickers suppor…
Sector: Biotechnology
Ticker: VXRT
Sentiment: 0.2944
MarketCap: 199,431,693.0
High: 1.31 Low: 1.21

Open: 1.29 Close: 1.22 Change: -0.07

Read more →
...
May 31, 2023 1:08 (London Time)

Vaxart

Vaxart Inc. (VXRT) has 135,597,316 shares trading at $1.20 per share. The total value of the stock is $162.72M. The market value is measured differe…
Sector: Biotechnology
Ticker: VXRT
Sentiment: 0.9716
MarketCap: 118,484,934.0
High: 1.35 Low: 1.18

Open: 1.25 Close: 1.23 Change: -0.02

Read more →
...
January 26, 2024 12:34 (London Time)

Vaxart

Vaxart, Inc. (Nasdaq: SGMT) soared 170% on Monday after the biopharmaceutical company announced… Funds from BARDA will support preparations for the …
Sector: Biotechnology
Ticker: VXRT
Sentiment: 0.9686
MarketCap: 124,460,717.0
High: 0.84 Low: 0.8

Open: 0.81 Close: 0.82 Change: 0.01

Read more →